Skip to main content
Pablo Pergola, MD, Nephrology, San Antonio, TX, Baptist Medical Center

PabloEzequielPergolaMDPhD

Nephrology San Antonio, TX

Renal Associates PA

Dr. Pergola is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pergola's full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center - San Antonio
    University of Texas Health Science Center - San AntonioFellowship, Nephrology, 1997 - 1999
  • University of Texas Health Science Center - San Antonio
    University of Texas Health Science Center - San AntonioResidency, Internal Medicine, 1994 - 1997
  • University of Salvador Faculty of Medicine
    University of Salvador Faculty of MedicineClass of 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1998 - 2022
  • American Board of Internal Medicine Nephrology
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • NRF2 Pathway: Why Is It Important in Kidney Diseases? 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Press Mentions

  • Reata Pharma Shares Trading Higher After Reacquiring U.S. And Worldwide Licensing Rights
    Reata Pharma Shares Trading Higher After Reacquiring U.S. And Worldwide Licensing RightsOctober 14th, 2019
  • Reata Announces Presentations at the 56thCongress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)
    Reata Announces Presentations at the 56thCongress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)June 4th, 2019
  • Effect of Bardoxolone Methyl on the Urine Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes and Stage 4 Chronic Kidney Disease
    Effect of Bardoxolone Methyl on the Urine Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes and Stage 4 Chronic Kidney DiseaseMay 16th, 2019
  • Join now to see all

Other Languages

  • Spanish

Hospital Affiliations